Partial agonist therapy in schizophrenia: Relevance to diminished criminal responsibility

Journal of Forensic Sciences

Volumn 55, Issue 6, 2010, Pages 1659-1662

  Gavaudan, Gilles ^a,b   Magalon, David ^b   Cohen, Julien ^b   Lançon, Christophe ^b   Léonetti, Georges ^a   Pélissier Alicot, Anne Laure ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Aripiprazole; Criminal responsibility; Dopamine; Forensic science; Pathological gambling; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CRIME; FORENSIC PSYCHIATRY; HUMAN; MALE; MIDDLE AGED; PATHOLOGICAL GAMBLING; SCHIZOPHRENIA; VIOLENCE;

ADULT; ANTIPSYCHOTIC AGENTS; CRIME; FORENSIC PSYCHIATRY; GAMBLING; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA; VIOLENCE;

EID: 78149305895     PISSN: 00221198     EISSN: 15564029     Source Type: Journal    
DOI: 10.1111/j.1556-4029.2010.01483.x     Document Type: Article

References (18)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, 4th edn. Washington, DC: American Psychiatric Association, 1995.
2. Blaszczynski A, Silove D. Pathological gambling: forensic issues. Aust N Z J Psychiatry 1996;30:358-69.
3. Petry NM, Stinson FS, Grant BF. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2005;66:564-74.
4. Shaffer HJ, Hall MN. Updating and refining prevalence estimates of disordered gambling behaviour in the United States and Canada. Can J Public Health 2001;92:168-72.
5. Grosset KA, Macphee G, Pal G, Stewart D, Watt A, Davie J, et al. Problematic gambling on dopamine agonists: not such a rarity. Mov Disord 2006;21:2206-8.
6. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 2007;22:1757-63.
7. Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 2007;68:301-3.
8. Chau DT, Roth RM, Green AI. The neural circuitry of reward and its relevance to psychiatric disorders. Curr Psychiatry Rep 2004;6:391-9.
9. Meyer G, Stadler MA. Criminal behavior associated with pathological gambling. J Gambl Stud 1999;15:29-43.
10. Noble EP. The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenomics 2000;1:309-33.
11. Bergh C, Eklund T, Sodersten P, Nordin C. Altered dopamine function in pathological gambling. Psychol Med 1997;27:473-5.
12. Comings DE, Rosenthal RJ, Lesieur HR, Rugle LJ, Muhleman D, Chiu C, et al. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 1996;6:223-34.
13. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005;62:1377-81.
14. Lieberman JA. Dopamine partial agonists: a new class of antipsychotic. CNS Drugs 2004;18:251-67.
15. Arimone Y, Begaud B, Miremont-Salame G, Fourrier-Reglat A, Molimard M, Moore N, et al. A new method for assessing drug causation provided agreement with experts' judgment. J Clin Epidemiol 2006;59:308-14.
16. Pallantini S, Bernardi S, Quercioli M, DeCaria C, Hollander E. Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo. CNS Spectr 2006;11:956-64.
17. Kessler RM. Aripiprazole: what is the role of dopamine D2 receptor partial agonism? Am J Psychiatry 2007;164:1310-2.
18. Drapier D, Drapier S, Sauleau P, Derkinderen P, Damier P, Allain H, et al. Pathological gambling secondary to dopaminergic therapy in Parkinson's disease. Psychiatry Res 2006;144:241-4.